Inventor · disambiguated record
David C. Litzinger
Also filed as: LITZINGER DAVID · LITZINGER DAVID C
17 granted patents·16 pending applications·244 citations·filing 2005–2024
94Inventor score
Top patents by PatentIndex Score
33 records- 0196US7638299B2Biosynthetic polypeptides utilizing non-naturally encoded amino acidsAMBRX INC·Filed 2005·Granted Dec 29, 2009·63 cites·11 claims
- 0295US8778880B2Human growth hormone modified at position 35CHO HO SUNG·Filed 2005·Granted Jul 15, 2014·25 cites·5 claims
- 0395US7816320B2Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35AMBRX INC·Filed 2005·Granted Oct 19, 2010·40 cites·18 claims
- 0494US7939496B2Modified human growth horomone polypeptides and their usesAMBRX INC·Filed 2005·Granted May 10, 2011·25 cites·4 claims
- 0592US8143216B2Modified human growth hormoneCHO HO SUNG·Filed 2007·Granted Mar 27, 2012·17 cites·4 claims
- 0690US8163695B2Formulations of human growth hormone comprising a non-naturally encoded amino acidHAYS ANNA-MARIA A·Filed 2007·Granted Apr 24, 2012·16 cites·2 claims
- 0789US8178494B2Modified human growth hormone formulations with an increased serum half-lifeHAYS ANNA-MARIA·Filed 2007·Granted May 15, 2012·18 cites·3 claims
- 0889US8093356B2Pegylated human interferon polypeptidesHAYS ANNA-MARIA A·Filed 2007·Granted Jan 10, 2012·19 cites·5 claims
- 0986US8907064B2Modified human four helical bundle polypeptides and their usesCHO HO SUNG·Filed 2007·Granted Dec 9, 2014·5 cites·18 claims
- 1083US8906676B2Modified human four helical bundle polypeptides and their usesCHO HO SUNG·Filed 2005·Granted Dec 9, 2014·3 cites·4 claims
- 1181US9260472B2Modified human four helical bundle polypeptides and their usesCHO HO SUNG·Filed 2007·Granted Feb 16, 2016·2 cites·18 claims
- 1279US2023115655A1Engineered polypeptides having enhanced duration of actionAMRYT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1378US9593154B2Engineered polypeptides having enhanced duration of actionAMYLIN PHARMACEUTICALS LLC·Filed 2013·Granted Mar 14, 2017·4 cites·10 claims
- 1474US9382304B2Engineered polypeptides having enhanced duration of action with reduced immunogenicityERICKSON MARY·Filed 2012·Granted Jul 5, 2016·6 cites·11 claims
- 1570US9879063B2Engineered polypeptides having enhanced duration of action and reduced immunogenicityAEGERION PHARMACEUTICALS INC·Filed 2015·Granted Jan 30, 2018·1 cites·14 claims
- 1668US11535659B2Engineered polypeptides having enhanced duration of actionAMRYT PHARMACEUTICALS INC·Filed 2020·Granted Dec 27, 2022·0 cites·8 claims
- 1767US2008207877A1Modified Human Four Helical Bundle Polypeptides and Their UsesAMBRX INC·Filed 2008·Application pending·0 cites
- 1866US2025049808A1Crystalline forms of a deoxycytidine kinase inhibitor and uses thereofTRETHERA CORP·Filed 2024·Application pending·0 cites
- 1963US2014296145A1Modified Human Growth Hormone Polypeptides and Their UsesAMBRX INC·Filed 2014·Application pending·0 cites
- 2062US2024033286A1Emollient topical disinfectantsI2PURE CORP·Filed 2023·Application pending·0 cites
- 2161US11446307B2Crystalline forms of a deoxycytidine kinase inhibitor and uses thereofTRETHERA CORP·Filed 2022·Granted Sep 20, 2022·0 cites·23 claims
- 2261US2010048871A1Biosynthetic Polypeptides Utilizing Non-Naturally Encoded Amino AcidsAMBRX INC·Filed 2009·Application pending·0 cites
- 2355US2022133735A1Crystalline forms of a deoxycytidine kinase inhibitor and uses thereofTRETHERA CORP·Filed 2021·Application pending·0 cites
- 2455US2013274182A1Engineered polypeptides having enhanced duration of actionASTRAZENECA PHARMACEUTICALS LP·Filed 2013·Application pending·0 cites
- 2554US11596648B2Emollient topical disinfectantsI2PURE CORP·Filed 2017·Granted Mar 7, 2023·0 cites·14 claims
- 2654US2016137709A1Engineered polypeptides having enhanced duration of actionAEGERION PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2754US2011294161A1Modified Human Growth HormoneCHO HO SUNG·Filed 2011·Application pending·0 cites
- 2852US2018305430A1Engineered Polypeptides Having Enhanced Duration of Action and Reduced ImmunogenicityAEGERION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2951US2010135959A1Human Interferon Molecules and Their UsesAMBRX INC·Filed 2006·Application pending·0 cites
- 3049US2011195899A1Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino AcidAMBRX INC·Filed 2010·Application pending·0 cites
- 3148US2014256621A1Engineered poypeptides having enhanced duration of action and reduced immunogenicityERICKSON MARY·Filed 2012·Application pending·0 cites
- 3243US2017114114A1Engineered polypeptides having enhanced duration of actionAMYLIN PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 3336US2018344813A1Engineered polypeptides having enhanced duration of action with reduced immunogenicityERICKSON MARY·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →